Fresenius Kabi Oncology Limited Oxaliplatin Export Data — India (DGFT 2022–2026)

Name: Fresenius Kabi Oncology Limited Oxaliplatin Export Records India — #1 Exporter, 602 Shipments, $16.6M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Oxaliplatin

India Pharmaceutical Trade Intelligence

$46.6M249 Suppliers123 CountriesHS 30049049

ExportsIndia → GERMANY21.5%India → RUSSIA13.9%

ImportsARGENTINA → India$44.5K ITALY → India$20.0K

#1 Supplier: FRESENIUS KABI #1 Buyer: FRESENIUS KABI

Fresenius Kabi Oncology Limited — Oxaliplatin Exporter #1 | $16.6M Trade Value | TransData Nexus | TransData Nexus

Fresenius Kabi Oncology Limited — Oxaliplatin Exporter Profile

Indian Pharmaceutical Exporter · #1 for Oxaliplatin · $16.6M export value · DGFT Verified

Fresenius Kabi Oncology Limited is the #1 Indian exporter of Oxaliplatin with $16.6M in export value and 602 verified shipments. Fresenius Kabi Oncology Limited holds a 35.7% market share in Oxaliplatin exports across 24 countries. The company exports 16 pharmaceutical products worth $117.2M across 3 therapeutic categories.

Fresenius Kabi Oncology Limited — Oxaliplatin Export Profile: Buyers & Destinations

Fresenius Kabi Oncology Limited Oxaliplatin export treemap — buyers and destination countries | TransData Nexus

Where Does Fresenius Kabi Oncology Limited Export Oxaliplatin?

Country	Value	Shipments	Share
GERMANY	$9.0M	362	66.1%
THAILAND	$1.4M	29	10.0%
COLOMBIA	$681.6K	19	5.0%
MALAYSIA	$657.5K	23

Who Are the Top Buyers of Oxaliplatin from Fresenius Kabi Oncology Limited?

Buyer	Country	Value	Orders
FRESENIUS KABI DEUTSCHLAND GMBH	GERMANY	$9.0M	362
FRESENIUS KABI (THAILAND) LTD	THAILAND	$625.2K	13
FRESENIUS KABI COLOMBIA SAS	COLOMBIA	$602.4K	17
FRESENIUS KABI MALAYSIA SDN BHD	MALAYSIA	$521.0K	19
FRESENIUS KABI THAILAND LTD	THAILAND	$328.9K	7
FRESENIUS KABI CHILE LTDA.	CHILE	$304.2K	8
FRESENIUS KABI THAILAND LIMITED	THAILAND	$150.0K	3
FRESENIUS KABI SOUTH AFRICA PTY L	SOUTH AFRICA	$150.0K	3
FRESENIUS KABI MEXICO S A DE C V	MEXICO	$131.6K	4
FRESENIUS KABI CHILE LTDA	CHILE	$117.2K	3

Fresenius Kabi Oncology Limited supplies Oxaliplatin to 67 buyers globally. The largest buyer is FRESENIUS KABI DEUTSCHLAND GMBH (GERMANY), followed by FRESENIUS KABI (THAILAND) LTD (THAILAND) and FRESENIUS KABI COLOMBIA SAS (COLOMBIA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Oxaliplatin Formulations Does Fresenius Kabi Oncology Limited Export?

Product Description / Formulation	Value	Shipments
OXALIPLATIN KABI INJ.200MG/40ML VIAL B.N	$607.6K	15
OXALIPLATIN KABI INJ.200MG/40ML VIAL(ITE	$286.2K	11
OXALIPLATINO INJECTION 100MG/20ML VIAL (	$203.5K	5
OXALIPLATINE FRESENIUS KABI INJ.200MG/40	$190.8K	9
OXALIPLATIN KABI INJ.100MG/20ML VIAL B.N	$170.7K	9
OXITAN ( OXALIPLATIN) INJ. 100MG/20ML VI	$154.3K	4
OXITAN OXALIPLATIN INJ. 50MG/10ML VIALB/N: 87230416AB 87230416AC MD:09/23 ED:08/25	$150.0K	3
OXALIPLATIN INJ. 200MG/40ML VIAL BATCH NO. 87250023AA, MFG. DT. 01/2025, EXP. DT. 12/2026	$136.0K	3
OXALIPLATINE KABI INJ.200MG/40ML VIAL B.	$130.9K	4
OXALIPLATIN FRESENIUS KABI INJ.200MG/40M	$129.2K	6

Fresenius Kabi Oncology Limited exports 461 distinct Oxaliplatin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is OXALIPLATIN KABI INJ.200MG/40ML VIAL B.N with 15 shipments worth $607.6K.

How Does Fresenius Kabi Oncology Limited Compare to Nearest Oxaliplatin Exporters?

Exporters ranked immediately above and below #1 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
1	FRESENIUS KABI ONCOLOGY LIMITED ★	$16.6M	602	24	$27.6K
3	SUN PHARMACEUTICAL INDUSTRIES LIMITED	$3.6M	113	3	$31.9K
4	ACCURE LABS PRIVATE LIMITED	$2.6M	78	2	$33.1K

Fresenius Kabi Oncology Limited ranks #1 among 249 Indian Oxaliplatin exporters. Average shipment value of $27.6K compared to the market average of $130.9K. The closest competitors by value are SUN PHARMACEUTICAL INDUSTRIES LIMITED and ACCURE LABS PRIVATE LIMITED.

Which Indian Ports Ship Oxaliplatin Exports?

Port	Shipments	% Share
DELHI AIR CARGO ACC (INDEL4)	535	17.4%
SAHAR AIR CARGO ACC (INBOM4)	453	14.7%
DELHI AIR	436	14.2%
SAHAR AIR	410	13.3%
CHAWAPAYAL ICD (INCPR6)	110	3.6%
Bombay Air	108	3.5%
NHAVA SHEVA SEA (INNSA1)	97	3.1%
CHAWAPAYAL ICD	95	3.1%

Geopolitical & Trade Policy Impact on Fresenius Kabi Oncology Limited's Oxaliplatin Exports

The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like FKOL. The Israel-Iran conflict has led to disruptions in Red Sea shipping routes, causing maritime carriers to suspend bookings and reroute vessels around the Cape of Good Hope. These changes have resulted in increased freight charges and extended transit times, posing significant risks to time-sensitive pharmaceutical shipments. The Pharmaceutical Export Promotion Council of India (Pharmexcil) estimates potential losses ranging from ₹2,500 crore to ₹5,000 crore due to these disruptions. (fortuneindia.com)

Conversely, U.S.-China trade tensions have created openings for Indian pharmaceutical companies. The U.S. has imposed tariffs on Chinese goods, including pharmaceuticals, prompting American importers to seek alternative suppliers. This shift has benefited Indian exporters, as evidenced by the U.S. accounting for approximately 34.5% of India's pharma exports, valued at around $10.5 billion. (actizaindustry.com) However, the U.S. administration's fluctuating tariff policies, including threats of increased tariffs on pharmaceutical imports, necessitate vigilance and adaptability from exporters like FKOL. (lemonde.fr)

In the European Union, regulatory changes such as the Falsified Medicines Directive (FMD) impose stringent requirements on pharmaceutical imports. Compliance with these regulations demands significant investment in serialization and traceability systems. For FKOL, ensuring adherence to such standards is crucial to maintaining access to the lucrative EU market and upholding its reputation for quality and reliability.

Fresenius Kabi Oncology Limited — Regulatory Compliance & Quality Standards

The global pharmaceutical industry is witnessing heightened regulatory scrutiny, with agencies like the FDA and WHO emphasizing Good Manufacturing Practices (GMP) compliance. Indian exporters, including FKOL, must navigate this evolving landscape to sustain their market positions. Notably, the FDA has increased inspections of Indian manufacturing facilities, with over 200 inspections conducted in 2023 and plans to escalate this number in 2024. (fact.net.in)

FKOL's commitment to quality is evident in its state-of-the-art Research & Development center in Gurgaon, India. The facility focuses on developing next-generation cytotoxic and cytostatic therapies, ensuring that products meet the highest quality standards irrespective of the target market. (fresenius-kabi-oncology.com) This proactive approach to quality assurance positions FKOL favorably in a competitive and regulated global market.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Oxaliplatin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Fresenius Kabi Oncology Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 608 individual customs records matching Fresenius Kabi Oncology Limited exporting Oxaliplatin, covering 461 formulations to 28 countries via 67 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 123+ countries, 693+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Oxaliplatin

Oxaliplatin

Fresenius Kabi Oncology Limited — Oxaliplatin Exporter Profile

Fresenius Kabi Oncology Limited — Oxaliplatin Export Profile: Buyers & Destinations

Where Does Fresenius Kabi Oncology Limited Export Oxaliplatin?

Who Are the Top Buyers of Oxaliplatin from Fresenius Kabi Oncology Limited?

What Is India's Total Oxaliplatin Export Value and How Much Does Fresenius Kabi Oncology Limited Contribute?

What Is the Average Shipment Value for Fresenius Kabi Oncology Limited's Oxaliplatin Exports?

How Does Fresenius Kabi Oncology Limited Compare to Other Indian Oxaliplatin Exporters?

What Oxaliplatin Formulations Does Fresenius Kabi Oncology Limited Export?

Regulatory Requirements: Exporting Oxaliplatin to Key Markets

Germany — BfArM/EMA

How Does Fresenius Kabi Oncology Limited Compare to Nearest Oxaliplatin Exporters?

Which Indian Ports Ship Oxaliplatin Exports?

What Other Advanced Oncology Products Does Fresenius Kabi Oncology Limited Export?

Oxaliplatin — Export Intelligence Video

Geopolitical & Trade Policy Impact on Fresenius Kabi Oncology Limited's Oxaliplatin Exports

Fresenius Kabi Oncology Limited — Regulatory Compliance & Quality Standards

About Fresenius Kabi Oncology Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Oxaliplatin Export Data from Fresenius Kabi Oncology Limited

Oxaliplatin Stats

Company Overview

Top Products by Fresenius Kabi Oncology Limited

Related Analysis

Need Detailed Export Data?

Data Source